Bresat Cancer Update
Oncology Leader CommentarySpecial FeaturesPrevious Issues
Home: Previous Issues: Web Guide 2: Clinical Trials Panel

2001 Miami Breast Cancer Conference
Davidson NE
Select, Recent Publications

Primary systemic therapy in operable breast cancer. [Review]. 
Wolff AC, Davidson NE. Journal of Clinical Oncology. 2000;18:1558-69.

Combined endocrine therapy for breast cancer--new life for an old idea? [editorial; comment]. 
Davidson NE. Journal of the National Cancer Institute. 2000;92:859-60.

American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. 
Smith TJ, Davidson NE, Schapira DV, et al. Journal of Clinical Oncology. 1999;17:1080-2.

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. 
Recht A, Gray R, Davidson NE, et al. Journal of Clinical Oncology. 1999;17:1689-700.

The biology of breast cancer. [Review]. 
Nass SJ, Davidson NE. Hematology - Oncology Clinics of North America. 1999;13:311-32.

Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma. 
Mikhak B, Zahurak M, Abeloff MD, et al. Cancer. 1999;85:899-904.

Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. [Review]. 
Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero RA Jr. Endocrine-Related Cancer. 1999;6:69-73.

The loss of estrogen and progesterone receptor gene expression in human breast cancer. [Review]. 
Lapidus RG, Nass SJ, Davidson NE. Journal of Mammary Gland Biology & Neoplasia. 1998;3:85-94.

Environmental estrogens and breast cancer risk. [Review]. 
Davidson NE. Current Opinion in Oncology. 1998;10:475-8.

Dose-dense sequential chemotherapy followed by high-dose consolidation (hdc): a phase i study in women with high-risk node-positive breast cancer (BC) (Meeting abstract). 
Kennedy MJ, Bond S, Davidson NE, et al. Proc Annu Meet Am Soc Clin Oncol. 17:A355, 1998.

Minimal acute toxicity associated with locoregional radiation therapy following 2 high-dose chemotherapy regimens (hdc) supported with autologous marrow/stem-cell transplantation in high risk breast cancer patients (Meeting abstract).
Gage I, Bond S, Davidson NE, et al. Proc Annu Meet Am Soc Clin Oncol. 17:A463, 1998.

Home · Contact us
Terms of use and general disclaimer